The role of BH3-only proteins in the immune system

Nature Reviews Immunology

Volumn 5, Issue 3, 2005, Pages 189-200

  Strasser, Andreas ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BH3 PROTEIN; PROTEIN BCL 2;

APOPTOSIS; AUTOIMMUNITY; IMMUNE DEFICIENCY; IMMUNE SYSTEM; LEUKEMIA; LYMPHOCYTE; LYMPHOMA; LYMPHOPOIESIS; PRIORITY JOURNAL; REVIEW;

ANIMALS; APOPTOSIS; HUMANS; IMMUNE SYSTEM; MODELS, BIOLOGICAL; MODELS, IMMUNOLOGICAL; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION;

EID: 14944348965     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri1568     Document Type: Review

References (126)

1. Marsden, V. & Strasser, A. Control of apoptosis in the immune system: Bcl-2, BH3-only proteins and more. Annu. Rev. Immunol. 21, 71-105 (2003).
2. Strasser, A., O'Connor, L. & Dixit, V. M. Apoptosis signaling. Annu. Rev. Biochem. 69, 217-245 (2000).
3. Danial, N. N. & Korsmeyer, S. J. Cell death: critical control points. Cell 116, 205-219 (2004).
4. Strasser, A., Harris, A. W., Huang, D. C. S., Krammer, P. H. & Cory, S. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 14, 6136-6147 (1995).
5. Nagata, S. Fas ligand-induced apoptosis. Annu. Rev. Genet. 33, 29-55 (1999).
6. Strasser, A., Harris, A. W. & Cory, S. Bcl-2 transgene inhibits Tcell death and perturbs thymic self-censorship. Cell 67, 889-899 (1991).
7. Strasser, A. et al. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc. Natl Acad. Sci. USA 88, 8661-8665 (1991).
8. Strasser, A., Harris, A. W., Corcoran, L. M. & Cory, S. Bcl-2 expression promotes B but not T lymphoid development in scid mice. Nature 368, 457-460 (1994).
9. Strasser, A., Harris, A. W., Von Boehmer, H. & Cory, S. Positive and negative selection of T cells in T cell receptor transgenic mice expressing a bcl-2 transgene. Proc. Natl Acad. Sci. USA 91, 1376-1380 (1994).
10. -/- mice. Cell 89, 1011-1019 (1997).
11. Newton, K., Harris, A. W., Bath, M. L. Smith, K. G. C. & Strasser, A. A dominant interfering mutant of FADD/Mort1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO J. 17, 706-718 (1998).
12. Newton, K., Harris, A. W. & Strasser, A. FADD/MORT1 regulates the pre-TCR checkpoint and can function as a tumour suppressor. EMBO J. 19, 931-941 (2000).
13. Kraus, M., Alimzhanov, M. B., Rajewsky, N. & Rajewsky, K. Survival of resting mature B lymphocytes depends on BCR signaling via the Igα/β heterodimer. Cell 117, 787-800 (2004).
14. Sprent, J. & Tough, D. F. T cell death and memory. Science 293, 245-248 (2001).
15. Strasser, A. & Pellegrini, M. T-lymphocyte death during shutdown of an immune response. Trends Immunol. 25, 610-615 (2004).
16. Gallimore, A. et al. induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J. Exp. Med. 187, 1383-1393 (1998).
17. Metcalf, D. The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells. Nature 339, 27-30 (1989).
18. Vaux, D. L. & Strasser, A. The molecular biology of apoptosis. Proc. Natl Acad. Sci. USA 93, 2239-2244 (1996).
19. Shi, Y. Mechanisms of caspase activation and inhibition during apoptosis. Mol. Cell 9, 459-470 (2002).
20. Enari, M. et al. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391, 43-50 (1998).
21. Liu, X., Zou, H., Slaughter, C. & Wang, X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89, 175-184 (1997).
22. Zhang, J., Cado, D., Chen, A., Kabra, N. H. & Winoto, A. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 392, 296-300 (1998).
23. Yen, W. C. et al. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 279, 1954-1958 (1998).
24. Varfolomeev, E. E. et al. Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 9, 267-276 (1998).
25. Wang, X. The expanding role of mitochondria in apoptosis. Genes Dev. 15, 2922-2933 (2001).
26. Marsden, V. et al. Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/ Apaf-1/caspase-9 apoptosome. Nature 419, 634-637 (2002).
27. Hara, H. et al. The apoptotic protease-activating factor 1 - mediated pathway of apoptosis is dispensable for negative selection of thymocytes. J. Immunol. 168, 2288-2295 (2002).
28. Marsden, V. S. et al. Bcl-2-regulated apoptosis and cytochrome c release can occur independently of both caspase-2 and caspase-9. J. Cell Biol. 165, 775-780 (2004).
29. Ricci, J. E. et al. Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain. Cell 117, 773-786 (2004).
30. Yin, X.-M. et al. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Narure 400, 886-891 (1999). This study shows that BID is required for death-receptor-induced apoptosis of hepatocytes but not lymphocytes.
31. Yin, X.-M., Oltvai, Z. N. & Korsmeyer, S. J. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369, 321-323 (1994).
32. Chittenden, T. et al. A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. EMBO J. 14, 5589-5596 (1995).
33. Huang, D. C. S., Adams, J. M. & Cory, S. The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4. EMBO J. 17, 1029-1039 (1998).
34. Veis, D. J., Sorenson, C. M., Shutter, J. R. & Korsmeyer, S. J. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75, 229-240 (1993).
35. Nakayama, K.-I. et al. Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice. Science 261, 1584-1588 (1993).
36. Motoyama, N. et al. Massive cell death of immature hematopoietic cells and neurons in Bcl-x deficient mice. Science 267, 1506-1510 (1995).
37. Ross, A. J. et al. Testicular degeneration in Bclw-deficient mice. Nature Genet. 18, 251-256 (1998).
38. Print, C. G. et al. Apoptosis regulator Bcl-w is essential for spermatogenesis but appears otherwise redundant. Proc. Natl Acad. Sci. USA 95, 12424-12431 (1998).
39. Xiang, Z. et al. Essential role of the prosurvival Bcl-2 homologue A1 in mast cell survival after allergic activation. J. Exp. Med. 194, 1561-1569 (2001).
40. Opferman, J. T. et al. Development and maintenance of B and T tymphocytes requires antiapoptotic MCL-1. Nature 426, 671-676 (2003).
41. Suzuki, M., Youle, R. J. & Tjandra, N. Structure of Bax: coregulation of dimer formation and intracellular localization. Cell 103, 645-654 (2000).
42. Lindsten, T. et al. The combined functions of proapoptotic Bcl-2 family members Bak and Bax are essential for normal development of multiple tissues. Mol. Cell 6, 1389-1399 (2000).
43. Rathmeil, J. C., Lindsten, T., Zong, W.-X., Cinalli, R. M. & Thompson, C. B. Deficiency in Bak and Bax perturbs thymic selection and lymphoid homeostasis. Nature Immunol. 3, 932-939 (2002). References 42 and 43 show that BAX and BAK have an overlapping essential role in programmed cell death and stress-induced apoptosis of lymphocytes and certain other cell types.
44. Ekert, P. G. et al. Apaf-1 and caspase-9 accelerate apoptosis, but do not determine whether factor-deprived or drug-treated cells die. J. Cell Biol. 165, 836-842 (2004).
45. Conradt, B. & Horvitz, H. R. The C. elegans protein EGL-1 is required for programmed cell death and interacts with the Bcl-2-like protein CED-9. Cell 93, 519-529 (1998). This study shows that the BH3-only protein EGL-1 is required for developmentally programmed cell death in C. elegans.
46. Bouillet, P. et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286, 1735-1738 (1999). This study shows that BIM is required for cytokine-withdrawal-induced and calcium-flux-induced apoptosis of lymphoid cells. It also shows that loss of BIM results in increased numbers of lymphoid and myeloid cells and leads to autoimmune disease.
47. Huang, D. C. S. & Strasser, A. BH3-only proteins - essential initiators of apoptotic cell death. Cell 103, 839-842 (2000). This is a review about BH3-only proteins.
48. L and Bcl-2, displaces Bax and promotes cell death. Cell 80, 285-291 (1995). This study describes the discovery of BAD.
49. Boyd, J. M. et al. Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene 11, 1921-1928 (1995).
50. Man, J., Sabbatini, P. & White, E. Induction of apoptosis by human Nbk/Bik, a BH3-containing protein that interacts with E1B 19K. Mol. Cell. Biol. 16, 5857-5864 (1996).
51. L, is a potent death agonist. J. Biol. Chem. 273, 7783-7786 (1998).
52. Wang, K., Yin, X.-M., Chao, D. T., Milliman, C. L. & Korsmeyer, S. J. BID: a novel BH3 domain-only death agonist. Genes Dev. 10, 2859-2869 (1996). This study describes the discovery of BID.
53. L. EMBO J. 16, 1686-1694 (1997).
54. Imaizumi, K. et al. Molecular cloning of a novel polypeptide, DP5, induced during programmed neuronal death. J. Biol. Chem. 272, 18842-18848 (1997).
55. O'Connor, L. et al. Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J. 17, 384-395 (1998).
56. Hsu, S. Y., Lin, P. & Hsueh, A. J. W. BOD (Bcl-2-related ovarian death gene) is an ovarian BH3 domain-containing proapoptotic Bcl-2 protein capable of dimerization with diverse antiapoptotic Bcl-2 members. Mol. Endocrinol. 12, 1432-1440 (1998). References 55 and 56 describe the discovery of BIM.
57. Oda, E. et al. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288, 1053-1058 (2000). This study describes the discovery of NOXA.
58. Nakano, K. & Vousden, K. H. PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell 7, 683-694 (2001).
59. Yu, J., Zhang, L. Hwang, P. M., Kinzler, K. W. & Vogelstein, B. PUMA induces the rapid apoptosis of colorectal cancer cells. Mol. Cell 7, 673-682 (2001). References 58 and 59 describe the discovery of PUMA.
60. Puthalakath, H. et al. Bmf: a pro-apoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis. Science 293, 1829-1832 (2001).
61. LBad peptide complex formation from structure, mutagenesis, and biophysical studies. Protein Sci. 9, 2528-2534 (2000).
62. L.
63. L sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol. Cell 8, 705-711 (2001).
64. Zong, W. X., Lindsten, T., Ross, A. J., MacGregor, G. R. & Thompson, C. B. BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev. 15, 1481-1486 (2001). References 63 and 64 show that BAX and/or BAK are required for the apoptosis that is induced by BH3-only proteins.
65. Marani, M., Tenev, T., Hancock, D., Downward, J. & Lemoine, N. R. Identification of novel isoforms of the BH3 domain protein Bim which directly activate Bax to trigger apoptosis. Mol. Cell. Biol. 22, 3577-3589 (2002).
66. Letai, A. et al. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2, 183-192 (2002).
67. Oltvai, Z. N., Milliman, C. L. & Korsmeyer, S. J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74, 609-619 (1993).
68. Wolter, K. G. et al. Movement of Bax from the cytosol to mitochondria during apoptosis. J. Cell Biol. 139, 1281-1292 (1997).
69. Cory, S. & Adams, J. M. The Bcl2 family: regulators of the cellular life-or-death switch. Nature Rev. Cancer 2, 647-656 (2002).
70. L can be regulated by their sequestration to the microtubular dynein-motor complex.
71. Zhu, Y. et al. Constitute association of the proapoptotc protein Bim with Bcl-2-related proteins on mitochondria in T cells. Proc. Natl Acad. Sci. USA 101, 7681-7686 (2004).
72. O'Reilly, L. A. et al. The pro-apoptotic BH3-only protein Bim is expressed in hemopoietic, epithelial, neuronal and germ cells. Am. J. Path. 157, 449-461 (2000).
73. Villunger, A., Scott, C., Bouillet, P. & Strasser, A. Essential role for the BH3-only protein Bim but redundant roles for Bax, Bcl-2, and Bcl-w in the control of granulocyte survival. Blood 101, 2393-2400 (2003).
74. Bouillet, P. et al. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes Nature 415, 922-926 (2002). This study and reference 77 show that BIM is required for the apoptosis of autoreactive thymocytes (that is, for negative selection).
75. + thymocytes requires the BH3-only protein Bim but is independent of death receptor signaling. Proc. Natl Acad. Sci. USA 101, 7052-7057 (2004).
76. Davey, G. M. et al. Peripheral deletion of autoreactive CD8 T cells by cross presentation of self-antigen occurs by a Bcl-2-inhibitable pathway mediated by Bim. J. Exp. Med. 196, 947-955 (2002).
77. Enders, A. et al. Loss of the pro-apoptotic BH3-only Bcl-2 family member Bim inhibits BCR stimulation-induced apoptosis and deletion of autoreative B cells. J. Exp. Med. 198, 1119-1126 (2003).
78. Hildeman, D. A. et al. Activated T cell death in vivo mediated by pro-apoptotic Bcl-2 family member, Bim. Immunity 16, 759-767 (2002).
79. Pellegrini, M., Belz, G., Bouillet, P. & Strasser, A. Shut down of an acute T cell immune response to viral infection is mediated by the pro-apoptotic Bcl-2 homology 3-only protein Bim. Proc. Natl Acad Sci. USA 100, 14175-14180 (2003). References 78 and 79 show that BIM is required for termination of T-cell responses.
80. Krammer, P. H. CD95's deadly mission in the immune system. Nature 407, 789-795 (2000).
81. Russell, J, H., Rush, B., Weaver, C. & Wang, R. Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc. Natl Acad. Sci. USA 90, 4409-4413 (1993).
82. Alderson, M. R. et al. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181, 71-77 (1995).
83. Puthalakath, H. & Strasser, A. Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins. Cell Death Differ. 9, 505-512 (2002).
84. Dijkers, P. F., Medemadagger, R. H., Lammers, J. J., Koenderman, L. & Coffer, P. J. Expression of the proapoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1. Curr. Biol. 10, 1201-1204 (2000). This study shows that BIM can be regulated transcriptionally by the forkhead transcription factor FOX03A.
85. Ley, R., Balmanno, K., Hadfield, K., Weston, C. & Cook, S. J. Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, Bim. J. Biol. Chem. 278, 18811-18816 (2003).
86. Akiyama, T. et al. Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim. EMBO J. 22, 6653-6664 (2003).
87. Luciano, F. et al. Phosphorylation of Bim-EL by Erk1/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function. Oncogene 22, 6785-6793 (2003). References 85-87 show that BIM can be regulated by ERK-mediated phosphorylation, which controls BIM ubiquitylation and proteasomal degradation.
88. Lei, K. & Davis, R. J. JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis. Proc. Natl Acad. Sci. USA 100, 2432-2437 (2003).
89. Putcha, G. V. et al. JNK-mediated BIM phosphorylation potentiates BAX-dependent apoptosis. Neuron 38, 899-914 (2003).
90. Putcha, G. V. et al. Induction of Bim, a proapoptotic BH3-only Bcl-2 family member, is critical for neuronal apoptosis. Neuron 29, 615-628 (2001).
91. Whitfield, J., Neame, S. J., Paquet, L., Bernard, O. & Ham, J. Dominant-negative c-Jun promotes neuronal survival by reducing BIM expression and inhibiting mitochondrial cytochrome c release. Neuron 29, 629-643 (2001).
92. Han, J. et al. Expression of bbc3, a pro-apoptotic BH3-only gene, is regulated by diverse cell death and survival signals. Proc. Natl Acad. Sci. USA 98, 11318-11323 (2001).
93. Coultas, L., Huang, D. C. S., Adams, J. M. & Stresser, A. Pro-apoptotic BH3-only Bcl-2 family members in vertebrate model organisms suitable for genetic experimentation. Cell Death Differ. 9, 1163-1166 (2002).
94. Strasser, A., Harris, A. W., Jacks, T. & Cory, S. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell 79, 329-339 (1994).
95. Villunger, A. et al. p53- and drug-induced apoptotic responses mediated by BH3-only proteins Puma and Noxa. Science 302, 1036-1038 (2003).
96. Jeffers, J. R. et al. Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 4, 321-328 (2003).
97. Shibue, T. et al. Integral role of Noxa in p53-mediated apoptotic response. Genes Dev. 17, 2233-2238 (2003). References 95-97 show that PUMA, and to a lesser extent NOXA, are essential for DNA-damage-induced apoptosis mediated by p53.
98. L. Cell 87, 619-628 (1996).
99. del Peso, L., Gonzalez-Garcia, M., Page, C., Herrera, R. & Nuñez, G. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278, 687-689 (1997).
100. Datta, S. R. et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91, 231-241 (1997). References 98-100 show that stimulation of cells with growth factors causes inactivation of BAD through AKT-mediated phosphorylation.
101. Ranger, A. M. et al. Bad-deficient mice develop diffuse large B cell lymphoma. Proc. Natl Acad. Sci. USA 100, 9324-9329 (2003).
102. Chou, J. J., Li, H., Salvesen, G. S., Yuan, J. & Wagner, G. Solution structure of BID, an intraceliular amplifier of apoptotic signaling. Cell 96, 615-624 (1999).
103. McDonnell, J. M., Fushman, D., Milllman, C. L., Korsmeyer, S. J. & Cowburn, D. Solution structure of the proapoptotic molecule BID: a structural basis for apoptotic agonists and antagonists. Cell 96, 625-634 (1999).
104. Luo, X., Budlhardjo, I., Zou, H., Slaughter, C. & Wang, X. Bid, a Bcl-2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94, 481-490 (1998).
105. Li, H., Zhu, H., Xu, C.-J. & Yuan, J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94, 491-501 (1998). References 104 and 105 show that BID can be activated by caspase-8-mediated proteolysis.
106. Sutton, V. R. et al. Initiation of apoptosis by granzyme B requires direct cleavage of Bid, but not direct granzyme B-mediated caspase activation. J. Exp. Med. 192, 1403-1414 (2000).
107. Heibein, J. A. et al. Granzyme B-mediated cytochrome c release is regulated by the Bcl-2 family members Bid and Bax. J. Exp. Med. 192, 1391-1402 (2000). References 106 and 107 show that the pro-apoptotic activity of BID can be activated by granzyme-B-mediated proteolysis.
108. Jiang, A. & Clark, E. A. Involvement of Bik, a proapoptotic member of the Bcl-2 family, in surface IgM-mediated B cell apoptosis. J. Immunol. 166, 6025-6033 (2001).
109. Coultas, L. et al. Proapoptotic BH3-only Bcl-2 family member Bik/Blk/Nbk is expressed in hemopoietic and endothelial cells but is redundant for their programmed death. Mol. Cell. Biol. 24, 1570-1581 (2004).
110. Sanz, C. et al. Specific and rapid induction of the proapoptotic protein Hrk after growth factor withdrawal in hematopoietic progenitor cells. Blood 95, 2742-2747 (2000).
111. Imaizumi, K. et al. Critical role for DP5/Harakiri, a Bcl-2 homology domain 3-only Bcl-2 family member, in axotomy-induced neuronal cell death. J. Neurosci. 24, 3721-3725 (2004).
112. Vaux, D. L., Cory, S. & Adams, J. M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335, 440-442 (1988).
113. Strasser, A., Harris, A. W., Bath, M. L. & Cory, S. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature 348, 331-333 (1990).
114. Zinkel, S. S. et al. Proapoptotic BID is required for myeloid homeostasis and tumor suppression. Genes Dev. 17, 229-239 (2003).
115. Egle, A., Harris, A. W., Bouillet, P. & Cory, S, Bim is a suppressor of Myc-induced mouse B cell leukemia. Proc. Natl Acad. Sci. USA 101, 6164-6169 (2004). References 114 and 115 show that loss of BID or BIM can promote lymphomagenesis.
116. Kuribara, R. et al. Roles of Bim in apoptosis of normal and Bcr-Abl-expressing hematopoietic progenitors. Mol. Cell. Biol. 24, 6172-6183 (2004). This study shows that BIM Is required for killing of a CML-derived cell line with the designer anticancer drug imatinib (Gleevec).
117. Wakeland, E. K., Liu, K., Graham, R. R. & Behrens, T. W. Delineating the genetic basis of systemic lupus erythematosus. Immunity 15, 397-408 (2001).
118. Bouillet, P., Cory, S., Zhang, L.-C., Strasser, A. & Adams, J. M. Degenerative disorders caused by Bcl-2 deficiency are prevented by loss of its BH3-only antagonist Bim. Dev. Cell 1, 645-653 (2001). This study shows that loss of BIM prevents the immunodeficiency and other degenerative disorders that are caused by loss of BCL-2.
119. Pellegrini, M. et al. Loss of Bim increases T cell production and function in interleukin 7 receptor-deficient mice, J. Exp. Med. 200, 1189-1195 (2004).
120. Oliver, P. M. et al. Loss of Bim allows precursor B cell survival but not precursor B cell differentiation in the absence of interleukin 7. J. Exp. Med. 200, 1179-1187 (2004).
121. Akashi, K., Kondo, M., von Freeden-Jeffry, U., Murray, R. & Weissman, I. L. Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell 89, 1033-1041 (1997).
122. Smith, K. G. C., Strasser, A. & Vaux, D. L. CrmA expression in T lymphocytes of transgenic mice inhibits CD95 (Fas/APO-1)-transduced apoptosis, but does not cause lymphadenopathy or autoimmune disease. EMBO J. 15, 5167-5176 (1996).
123. Hsu, S. Y., Kaipia, A., McGee, E., Lomeli, M. & Hsueh, A. J. W. Bok is a pro-apoptotic Bcl-2 protein with restricted expression in reproductive tissues and heterodimerizes with selective anti-apoptotic Bcl-2 family members. Proc. Natl Acad. Sci. USA 94, 12401-12406 (1997).
124. L. J. Biol. Chem. 273, 8705-8710 (1998).
125. Guo, B., Godzik, A. & Reed, J. C. Bcl-G, a novel proapoptotic member of the Bcl-2 family. J. Biol. Chem. 276, 2780-2785 (2001).
126. Coultas, L. et al. Bfk: a novel weakly proapoptotic member of the Bcl-2 protein family with a BH3 and a BH2 region. Cell Death Differ. 10, 185-192 (2003).